These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 35231612

  • 1. Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment.
    Tardif I, Guénette L, Zongo A, Demers É, Lunghi C.
    Diabetes Metab; 2022 Jul; 48(4):101334. PubMed ID: 35231612
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes.
    Johnson JA, Simpson SH, Toth EL, Majumdar SR.
    Diabet Med; 2005 Apr; 22(4):497-502. PubMed ID: 15787679
    [Abstract] [Full Text] [Related]

  • 4. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT, Chang KC, Li CY, Wu JS.
    Cardiovasc Diabetol; 2016 Mar 01; 15():41. PubMed ID: 26932742
    [Abstract] [Full Text] [Related]

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004 Mar 01; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 6. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
    Simeone JC, Quilliam BJ.
    Ann Pharmacother; 2012 Feb 01; 46(2):157-68. PubMed ID: 22234990
    [Abstract] [Full Text] [Related]

  • 7. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
    Zghebi SS, Steinke DT, Rutter MK, Emsley RA, Ashcroft DM.
    Diabetes Obes Metab; 2016 Sep 01; 18(9):916-24. PubMed ID: 27177784
    [Abstract] [Full Text] [Related]

  • 8. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
    Koro CE, Bowlin SJ, Weiss SR.
    Pharmacoepidemiol Drug Saf; 2005 Oct 01; 14(10):697-703. PubMed ID: 15654719
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.
    Chang YC, Chuang LM, Lin JW, Chen ST, Lai MS, Chang CH.
    Diabet Med; 2015 Nov 01; 32(11):1460-9. PubMed ID: 25970814
    [Abstract] [Full Text] [Related]

  • 10. Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case-control study.
    Wium-Andersen IK, Osler M, Jørgensen MB, Rungby J, Wium-Andersen MK.
    Eur J Endocrinol; 2019 Nov 01; 181(5):499-507. PubMed ID: 31437816
    [Abstract] [Full Text] [Related]

  • 11. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    Hippisley-Cox J, Coupland C.
    BMJ; 2016 Jul 12; 354():i3477. PubMed ID: 27413012
    [Abstract] [Full Text] [Related]

  • 12. Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case-control study.
    Wang MT, Lai JH, Huang YL, Kuo FC, Wang YH, Tsai CL, Tu MY.
    Respir Res; 2020 Dec 02; 21(1):319. PubMed ID: 33267895
    [Abstract] [Full Text] [Related]

  • 13. Association Between Metformin Adherence and All-Cause Mortality Among New Users of Metformin: A Nested Case-Control Study.
    Simard P, Presse N, Roy L, Dorais M, White-Guay B, Räkel A, Perreault S.
    Ann Pharmacother; 2018 Apr 02; 52(4):305-313. PubMed ID: 29144162
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression.
    Lunghi C, Zongo A, Moisan J, Grégoire JP, Guénette L.
    J Diabetes Complications; 2017 Jul 02; 31(7):1200-1206. PubMed ID: 28325698
    [Abstract] [Full Text] [Related]

  • 15. Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients.
    Rea F, Savaré L, Valsassina V, Ciardullo S, Perseghin G, Corrao G, Mancia G.
    Cardiovasc Diabetol; 2023 Mar 10; 22(1):53. PubMed ID: 36899347
    [Abstract] [Full Text] [Related]

  • 16. Diabetes, antidiabetic medications and risk of depression - A population-based cohort and nested case-control study.
    Wium-Andersen IK, Osler M, Jørgensen MB, Rungby J, Wium-Andersen MK.
    Psychoneuroendocrinology; 2022 Jun 10; 140():105715. PubMed ID: 35338947
    [Abstract] [Full Text] [Related]

  • 17. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Losada E, Soldevila B, Ali MS, Martínez-Laguna D, Nogués X, Puig-Domingo M, Díez-Pérez A, Mauricio D, Prieto-Alhambra D.
    Osteoporos Int; 2018 Sep 10; 29(9):2079-2086. PubMed ID: 29860664
    [Abstract] [Full Text] [Related]

  • 18. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Sep 10; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 19. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
    Franchi M, Asciutto R, Nicotra F, Merlino L, La Vecchia C, Corrao G, Bosetti C.
    Eur J Cancer Prev; 2017 May 10; 26(3):225-231. PubMed ID: 27222938
    [Abstract] [Full Text] [Related]

  • 20. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure.
    Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA.
    Diabetes Care; 2005 Oct 10; 28(10):2345-51. PubMed ID: 16186261
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.